OA11820A - Functionalized heterocycles as chemokine receptor modulators. - Google Patents

Functionalized heterocycles as chemokine receptor modulators. Download PDF

Info

Publication number
OA11820A
OA11820A OA1200100187A OA1200100187A OA11820A OA 11820 A OA11820 A OA 11820A OA 1200100187 A OA1200100187 A OA 1200100187A OA 1200100187 A OA1200100187 A OA 1200100187A OA 11820 A OA11820 A OA 11820A
Authority
OA
OAPI
Prior art keywords
methyl
benzopyrano
decahydro
carboxylic acid
quinolizine
Prior art date
Application number
OA1200100187A
Other languages
English (en)
Inventor
Geraldine C Harriman
Christine Nylund Kolz
Jay R Luly
Bruce David Roth
Yuntao Song
Bharat Kalidas Trivedi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of OA11820A publication Critical patent/OA11820A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA1200100187A 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators. OA11820A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11565499P 1999-01-13 1999-01-13

Publications (1)

Publication Number Publication Date
OA11820A true OA11820A (en) 2005-08-17

Family

ID=22362668

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100187A OA11820A (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators.

Country Status (20)

Country Link
EP (1) EP1144415A2 (xx)
JP (1) JP2002534526A (xx)
KR (1) KR20010086166A (xx)
CN (1) CN1344270A (xx)
AP (1) AP2001002228A0 (xx)
AU (1) AU1940900A (xx)
BR (1) BR9916905A (xx)
CA (1) CA2372197A1 (xx)
CZ (1) CZ20012502A3 (xx)
EA (1) EA200100774A1 (xx)
HK (1) HK1044539A1 (xx)
HU (1) HUP0202932A3 (xx)
IL (1) IL144289A0 (xx)
MX (1) MXPA01007033A (xx)
NO (1) NO20013456L (xx)
OA (1) OA11820A (xx)
PL (1) PL349348A1 (xx)
SK (1) SK9972001A3 (xx)
WO (1) WO2000042045A2 (xx)
ZA (1) ZA200106592B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072549A1 (en) * 2001-03-12 2002-09-19 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
DK1379239T3 (da) 2001-03-29 2008-01-07 Lilly Co Eli N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
WO2003035650A1 (fr) * 2001-09-25 2003-05-01 Takeda Chemical Industries, Ltd. Inhibiteur d'entree
MXPA05009771A (es) 2003-03-14 2005-10-26 Ono Pharmaceutical Co Derivados heterociclicos que contienen nitrogeno y medicamentos que los contienen como el ingrediente activo.
WO2004092169A1 (ja) 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
AU2005283326B2 (en) 2004-09-13 2011-07-21 Ono Pharmaceutical Co., Ltd. Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
WO2006129679A1 (ja) 2005-05-31 2006-12-07 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
JP5251127B2 (ja) 2005-10-28 2013-07-31 小野薬品工業株式会社 塩基性基を含有する化合物およびその用途
PT1961744E (pt) 2005-11-18 2013-05-15 Ono Pharmaceutical Co Composto que contém um grupo básico e sua utilização
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
BRPI0707873A2 (pt) * 2006-02-15 2011-05-10 Allergan Inc compostos amida, Éster, tioamida e tiol Éster do Ácido indol-3-carboxÍlico carregando grupos arila ou heteroarila tendo atividade biolàgica antagonista de recptor de esfingosina-1-fosfato (s1p)
BRPI0708731A2 (pt) 2006-03-10 2011-06-07 Ono Pharmaceutical Co derivado heterocìclico nitrogenado, e agente farmacêutico compreendendo o derivado como ingrediente ativo
WO2007132846A1 (ja) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. 保護されていてもよい酸性基を含有する化合物およびその用途
US8329689B2 (en) 2006-05-23 2012-12-11 Alexandre Vasilievich Ivachtchenko Substituted indoles and a method for the production and use thereof
US20090325992A1 (en) 2006-07-31 2009-12-31 Ono Pharmaceutical Co., Ltd. Compound having cyclic group bound thereto through spiro binding and use thereof
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
CN101668741A (zh) 2007-01-11 2010-03-10 阿勒根公司 具有鞘氨醇-1-磷酸(s1p)受体拮抗剂生物学活性的6-取代吲哚-3-羧酸酰胺化合物
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CN102958927A (zh) 2010-05-12 2013-03-06 Abbvie公司 激酶的吲唑抑制剂
WO2013024022A1 (en) 2011-08-12 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treatment of pulmonary hypertension
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر
CN104193669B (zh) * 2014-08-01 2016-12-07 大连理工大学 一类阿比朵尔类似物或其盐、其制备方法及应用
WO2016112088A1 (en) * 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
CN110256324A (zh) * 2019-06-13 2019-09-20 苏州莱安医药化学技术有限公司 一种2-甲基-5-羟基吲哚的制备方法
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
US3518258A (en) * 1967-05-09 1970-06-30 Warner Lambert Pharmaceutical Pyrano(3,2-i)quinolizine and process for the production
US3565903A (en) * 1967-11-24 1971-02-23 Warner Lambert Pharmaceutical Pyrano(2,3-b)quinolines and process for their production
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
BR9807858A (pt) * 1997-02-26 2000-02-22 Pfizer Derivados de amida do ácido heteroaril-hexanóico, suas preparaçÊes e seus usos como inibidores seletios de mip-1.alfa ligando aos seus receptores ccr1
CA2319781A1 (en) * 1998-02-02 1999-08-05 Liping Wang Cyclic amine modulators of chemokine receptor activity

Also Published As

Publication number Publication date
KR20010086166A (ko) 2001-09-08
JP2002534526A (ja) 2002-10-15
AU1940900A (en) 2000-08-01
HK1044539A1 (zh) 2002-10-25
NO20013456L (no) 2001-09-12
AP2001002228A0 (en) 2001-09-30
NO20013456D0 (no) 2001-07-12
WO2000042045A2 (en) 2000-07-20
EP1144415A2 (en) 2001-10-17
CZ20012502A3 (cs) 2002-03-13
MXPA01007033A (es) 2003-07-21
CN1344270A (zh) 2002-04-10
EA200100774A1 (ru) 2002-02-28
IL144289A0 (en) 2002-05-23
SK9972001A3 (en) 2002-03-05
PL349348A1 (en) 2002-07-15
HUP0202932A3 (en) 2003-07-28
WO2000042045A3 (en) 2000-11-09
CA2372197A1 (en) 2000-07-20
BR9916905A (pt) 2002-01-29
HUP0202932A2 (hu) 2002-12-28
ZA200106592B (en) 2002-08-12

Similar Documents

Publication Publication Date Title
OA11820A (en) Functionalized heterocycles as chemokine receptor modulators.
DK171232B1 (da) Azabicycliske forbindelser og fremgangsmåde til deres fremstilling
Cava et al. Photochemical routes to aporphines. New syntheses of nuciferine and glaucine
US20030064991A1 (en) Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
JP2008511669A6 (ja) 化合物
JP2008511669A (ja) 化合物
DK171641B1 (da) Disubstituerede prolinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse
JP2009507795A (ja) 化合物
DE69430752T2 (de) Tetracyclische verbindungen
NO884008L (no) Fremgangsmaate for fremstilling av 3,7-diazabicyclo(3,3,1)nonanforbindelser.
AU631723B2 (en) Tricyclic-cyclic amines as novel cholinesterase inhibitors
Molina et al. Fused carbazoles by tandem Aza Wittig/electrocyclic ring closure. Preparation of 6H-pyrido [4, 3-b] carbazole, 11H-pyrido [4, 3-a] carbazole and 11H-pyrido [3, 4-a] carbazole derivatives
US4925867A (en) Hydrocarbon substituted pyrrolidinones, intermediates therefor, and anti-convulsant use thereof
JP2010053042A (ja) カリウムチャネル調節薬
EP0222703A1 (de) Hexahydro-[1]-benzo-(pyrano und thiopyrano)-[4,3-c]pyridine
JP3541952B2 (ja) ４−アリールイソインドール鎮痛薬
IE901063L (en) Polycyclic amines useful as cerebrovascular agents
KR910002564B1 (ko) 헥사하이드로피롤로[2,1-a]이소퀴놀린 유도체의 제조방법
EP0279548B1 (en) Substituted 1,3,4,9-tetrahydropyrano [3,4-b] indole-1-acetic acids
US3583997A (en) Benzothiopyrano(2,3-c)pyridines
Wang et al. Concise synthesis of benzoindolizidine derivatives and bioactivity evaluation
Al-Lakkis-Wehbe et al. Regioselective synthesis of the 1-bromo-4-phenyl-tetrahydro-7-amino-benzocyclohepten-6-one, a subnanomolar aminopeptidase-N/CD13 inhibitor
WO2001014385A1 (fr) Derives de dihydrobenzofuran, leur procede de preparation et agents
JPH0725741B2 (ja) 複素環式化合物
US5587486A (en) 1-amino-2-cyclohexene derivative and production process therefor